Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Biotech/Pharma - Finance
Vitamfero Successfully Secures Its Third Round Of Financing 9/30/2014 2:29:21 PM
MYMETICS Corporation’ Promising HIV Vaccine Candidate Obtains Funding To Begin Study At Texas Biomedical Research Institute 9/30/2014 12:13:16 PM
Twist Bioscience Secures $10 Million Loan Facility 9/30/2014 9:00:20 AM
ChromaDex, Inc. Secures $5.0 Million In Growth Capital Financing From Hercules 9/30/2014 8:13:43 AM
National Photonics Initiative Release: US Photonics Industry Leaders Commit Upwards Of $30M To Support The President's BRAIN Initiative 9/30/2014 11:10:42 AM
Pittsburgh Business Leader Henry L. Hillman Provides $5 Million Gift For Carnegie Mellon University's New Brainhub(SM) Initiative 9/30/2014 9:04:31 AM
Argos Therapeutics, Inc. (ARGS) Enters Into $25 Million Venture Loan Facility Led By Horizon Technology Finance 9/30/2014 8:25:13 AM
Bay Area Startup Allakos Locks In Another $10 Million 9/30/2014 6:26:30 AM
AVANIR Pharmaceuticals (AVNR) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/29/2014 10:08:58 AM
Agrisoma Biosciences Inc. Announces Closing Of Series A Round 9/29/2014 9:55:53 AM
Atox Bio Awarded Contract Worth Up To $24 Million For The Development Of AB103 By The Biomedical Advanced Research and Development Authority (BARDA) 9/29/2014 7:10:21 AM
AVEO Oncology (AVEO) Terminates Cambridge Lease Agreement To Save $110 Million 9/26/2014 6:41:47 AM
Backed By A Baidu Founder, Allele Biotechnology Raises $7 Million To Reprogram Stem Cells 9/25/2014 6:33:34 AM
UK Biotech Firm Adaptimmune Ltd. Attracts $104 Million Investment 9/25/2014 6:41:35 AM
Emeryville Cancer Drug Developer Eureka Therapeutics Lands $21 Million From Chinese, Other Investors 9/25/2014 7:12:01 AM
1234567
//-->